Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 9, Issue 3, 2007, Pages 187-195

  Giles, Thomas D ^a   Oparil, Suzanne ^a   Silfani, Tonous N ^a   Wang, Antonia ^a   Walker, J Findlay ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; LOSARTAN; OLMESARTAN; TETRAZOLE DERIVATIVE; VALINE; VALSARTAN;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG EFFECT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 34247181619     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.06395.x     Document Type: Article

References (0)